The founding partners of the National Science Foundation Southwest I-Corps Node, co-established by Rice University, have been awarded a $15 million grant to form a hub that will expand the partnership to five additional universities.
Researchers at Rice University will team with counterparts at MD Anderson to improve cancer therapy with the support of seed funding from the John S. Dunn Foundation.
Rice bioengineers have created the first tool for observing the real-time activity of biology’s most ubiquitous signal-processing circuits.
The Rice University NLM Training Program in Biomedical Informatics and Data Science wins a $4.16 million National Library of Medicine grant.
Rice and Baylor researchers have used Rice’s “drug factory” implants to eradicate advanced-stage mesothelioma tumors in mice.
Rice University receives National Science Foundation support to turn living cells, starting with bacteria, into random-access memory devices. These will be able to store and report data about their environments.
A record 17 graduate students at Rice University have been named 2022 Fellows of the National Graduate Education for Minorities Consortium.
Rice and Baylor College of Medicine are creating tiny implants that can heal damage from heart attacks.
Rice’s Naomi Halas and Peter Nordlander have won the prestigious 2022 Eni Energy Transition Award.
Federal regulators have approved the first human clinical trial of cancer-killing “drug factory” implants created by Rice bioengineers.
Bioengineers used deactivated Cas9 fusion proteins to synthetically control gene expression and reveal new details about natural processes in human cells.
Just steps away from Rice University, you can meet Neptune, Luna, Vidalia, Artemis and Ophelia, the Houston Zoo’s resident red river hogs.
Rice bioengineers are ready to shine a lot of light on bacteria’s genetic response to stress.
Rice University recruits three professors to bolster cancer research with grants from the Cancer Prevention and Research Institute of Texas.
Rice engineers introduce DAP, a streamlined CRISPR-based technology that can perform many genome edits at once to address polygenic diseases caused by more than one glitch.